GERON BIO Co., Ltd. (CEO Lee Sang-eun) announced that it will participate in CES 2024, which will be held in Las Vegas, USA from Tuesday, January 9th to January 12th (Friday, local time) next year.
GERON BIO is working to create a healthy future with products and services mainly centered on Theranosis and microneedle technology. Our goal is to effectively solve joint health problems caused by aging and introduce Geron Bio’s innovative healthcare solutions developed with Theranosis technology to the world.
This CES will introduce non-invasive and effective treatments by emphasizing the integration of transdermal absorption technology, medical gel, and medical devices. In addition, we introduce ‘Novacell Patch’, a facial wrinkle improvement solution using needle patch technology. GERON BIO’s microneedles are known to have a unique structure that utilizes skin elasticity to accurately maintain the material loading area within the skin.
Regarding this, a company official said, “Our advanced microneedle technology boasts several competitive advantages and features, including accurate drug dose placement, consistent and adjustable needle size, accurate delivery volume and release time, and effective pain control. “The high-performance microneedles are designed to accommodate parameter adjustments based on customer preferences, facilitating a variety of bedside applications,” he said. “Leak-free and rapid injection capabilities ensure meticulous depth and quantitative drug delivery. Additionally, this technology enables flexible manufacturing by incorporating microscale supports. “A big feature is that by specifically adjusting the shape and length of the needle, the targeted drug can be delivered to the desired depth,” he explained.
GERON BIO is considering medical and healthcare companies, doctors and medical professionals, and stakeholders in the health and wellness industry as notable target customers in the United States. In particular, we seek to strengthen collaboration with medical professionals and research institutions interested in joint health issues and age-related diseases. In addition, we are seeking collaboration with buyers in the beauty and skin care industry who are interested in facial wrinkle improvement solutions such as Novacell Patch. Cooperation with partners and investors who will lead future medical technology in the global market was also selected as one of the important goals.
An official said, “GERON BIO will take the lead in providing innovative healthcare solutions for a healthy life for humanity through continuous research and development and expansion into the global market. In addition, we will strengthen our market competitiveness by launching a variety of products using Theranosys technology and strive to take a leading position in the global market,” he said. “We will continue to drive innovation through the launch of new products and services in the future to advance the medical field.” “We plan to grow into a global leading company,” he said.
Meanwhile, ‘CES’, the world’s largest IT exhibition hosted by the Consumer Technology Association (CTA), is an exhibition where you can see the flow of innovative technologies around the world at a glance and is held every January in Las Vegas, USA. AVING News, which has covered CES for 18 consecutive years, has reported CES news around the world every year since 2006, and has been selected through ‘BEST OF CES’ and ‘BEST OF MADE IN KOREA’, which select the best innovative products, companies and technologies. has been in progress. In addition, CES on-site issues are vividly conveyed through ‘AVING LIVE’.
The CES 2024 Seoul Unified Hall will be operated at the largest scale in terms of exhibition area, number of participating companies, and number of participating supporters since Seoul City’s first participation in CES in 2020. The Seoul Integration Center, in which 13 organizations collaborate and participate, is an important step in Seoul’s efforts to make Seoul a mecca for startups, and 17 of the companies participating in the Seoul Integration Center proved this by receiving innovation awards. The participating institutions in the Seoul Unification Center are ▲SBA ▲Seoul Bio Hub ▲Campus Town ▲AI Yangjae Hub ▲Gwanak-gu ▲Yonsei University ▲Korea University ▲Chung-Ang University ▲Sogang University ▲Kookmin University ▲Hanyang University ▲Konkuk University ▲Kyunghee University. Not only the Seoul Metropolitan Government, institutions, and companies, but also supporters through industry-academia cooperation are matched 1:1 with companies, and 85 supporters, the largest number, will participate.
* Special reporters: Joseph Choe, Kidai Kim, Dongkwan Kim, Mokkyung Lee, Sangun Choi, Seung Hyun Nam, Sunghwan Kim, Taeuck Lim, Min Choi
→ Go to the CES 2024 news special page